Editas Medicine Inc

Healthcare · Biotechnology

2.80$ +3.3% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Editas Medicine Inc (EDIT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 237 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EDIT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	242	229	395	369	339	373	404	394	388	420	379	356	372	509	467	655	597	573	780	756	717	677	623	581	531	514	464	542	505	499	440	385	328	342	264	211	202	187	149	237
Current Assets	203	187	354	328	298	332	363	348	343	375	347	324	339	464	425	610	507	419	632	616	568	507	497	461	427	357	324	441	359	341	306	286	271	289	225	183	177	164	128	218
Cash	200	185	352	144	87	147	218	132	112	135	158	211	105	238	233	486	280	140	355	338	260	204	211	169	211	142	129	221	83	124	69	64	96	132	139	139	166	147	124	182
Cash & Short-Term Investments	200	185	352	325	296	329	359	344	337	369	342	318	333	457	415	599	495	402	625	611	558	500	488	453	420	344	318	432	350	323	296	279	265	270	221	179	166	147	124	212
Receivables	1.1	0.1	0.9	0.8	0.7	0.7	0.9	0.4	0.0	0.0	0.0	0.0	0.3	0.4	1.8	1.9	1.1	6.0	0.7	0.3	0.3	0.3	1.4	0.7	0.1	5.1	0.2	2.3	2.4	10	0.2	0.2	0.1	16	0.5	0.6	8.1	15	2.6	2.7
Inventory	0.0	1.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.9	–	–	–	–	0.0	0.0	-46	-110	-98	-88	0.0	-120	0.0	–	–	-93	-83	-48	-9.0	–	–	0.0	–	–	–	–	–	–	–	–
Property, Plant & Equipment	37	40	40	39	39	39	40	40	40	40	26	26	28	40	39	41	14	14	14	15	16	17	17	16	15	16	13	13	43	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	72	95	189	184	161	165	156	162	163	184	162	163	162	246	232	229	156	179	142	143	130	124	110	115	116	154	147	142	144	150	146	153	152	207	201	191	188	159	145	132
Current Liabilities	14	33	50	49	29	37	31	24	26	36	41	73	67	60	69	68	55	58	64	66	51	47	37	36	42	60	57	55	59	63	66	74	72	77	73	66	62	46	40	68
Short-Term Debt	16	10	15	15	8.5	7.5	7.8	11	11	13	3.5	3.6	4.4	5.8	5.6	6.7	6.3	6.8	7.3	9.0	10	10	10	10	12	11	8.3	10	9.7	24	12	18	16	15	13	6.1	6.1	11	14	6.5
Accounts Payable	3.7	4.6	15	8.2	7.0	4.0	9.0	4.7	5.0	5.3	6.6	4.0	6.6	5.8	10	6.3	5.2	6.4	8.9	4.4	3.4	5.1	4.7	6.2	6.8	9.5	9.0	8.1	10	8.3	8.0	14	12	5.5	5.5	6.7	3.2	2.6	4.3	4.7
Long-Term Debt	32	35	34	34	34	33	33	33	33	–	15	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	170	135	206	185	178	208	248	231	224	236	217	193	210	262	235	427	441	394	638	613	587	554	513	465	415	361	317	400	360	349	294	232	176	134	62	19	13	27	4.4	105
Retained Earnings	-146	-186	-217	-243	-270	-306	-337	-376	-391	-416	-445	-479	-511	-549	-587	-611	-603	-665	-722	-777	-816	-858	-908	-962	-1,017	-1,078	-1,127	-1,167	-1,212	-1,231	-1,293	-1,361	-1,423	-1,468	-1,545	-1,598	-1,623	-1,629	-1,653	-1,672
Shares Outstanding	36	36	36	41	41	43	46	47	47	48	49	49	50	51	55	55	63	62	66	68	68	68	68	69	69	69	69	71	82	82	82	82	82	83	83	84	90	89	98	119

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings